logo
Rising Costs and Coverage Gaps: The Diverging Medical Insurance Landscapes in Hong Kong and Singapore

Rising Costs and Coverage Gaps: The Diverging Medical Insurance Landscapes in Hong Kong and Singapore

As Hong Kong witnesses a burgeoning interest in health insurance, Singapore grapples with the challenges of rising medical costs and financial risk management.
Budget Priorities: Respondents in both regions allocate significant portions of their budgets to Family, Finance, and Health. Notably, there is a strong intent to increase health budgets in 2025, particularly among the middle-income segment, with 31% in Singapore and 26% in Hong Kong planning for such increases.
Insurance Coverage Gaps: While a majority of respondents in both markets benefit from medical insurance, Singaporeans exhibit higher levels of protection, with 49% having personal plans and only 10% uninsured, compared to 19% uninsured in Hong Kong.
HNWIs Driving Demand: A substantial percentage of HNWIs in Hong Kong plan to purchase new medical insurance in 2025 (48%), contrasting with a smaller proportion in Singapore due to existing extensive coverage (30%).
Motivations and Barriers: Hong Kong respondents are driven to purchase insurance to address coverage gaps (44%) and rising medical expenses (36%), while Singaporeans focus on mitigating financial risks (43%). High costs remain the top deterrent in both markets, affecting 62% in Hong Kong and 52% in Singapore.
HONG KONG SAR - Media OutReach Newswire - 11 February 2025 - A recent survey by MDRi, which engaged 1,000 respondents across Hong Kong and Singapore, has unveiled a diverse array of health and medical insurance needs as the Year of the Snake approaches. The findings highlight the contrasting priorities of individuals in these two markets, revealing distinct trends in their insurance requirements.
Health has emerged as the paramount life priority for residents of both Hong Kong and Singapore. With a growing aging population in both markets, this shared emphasis on health underscores significant growth opportunities within the healthcare industry.
Middle-Income Segment Intends to Increase Health Budgets in 2025
In examining budget allocations for 2024, respondents from Hong Kong prioritized Family (23%), Finance (22%), and Health (15%). Singaporeans similarly allocated their budgets, with Family (22%), Finance (20%), and Health (16%) as top priorities.
Notably, 21% of Hong Kong respondents plan to increase their health budgets in 2025, particularly among the middle-income segment, where 26% intend to allocate more. In Singapore, 23% of respondents plan to boost their health budgets, with a striking 31% among the middle-income group.
Significant Differences in Medical Insurance Coverage
While the majority of individuals in both Hong Kong (81%) and Singapore (90%) have medical insurance coverage, notable differences arise in personal coverage. In Singapore, approximately 49% possess personal medical insurance, with 36% opting for additional coverage beyond company plans. In contrast, only 15% of Hong Kong respondents rely solely on company medical insurance without personal coverage, and about 19% of individuals in Hong Kong lack any medical insurance, compared to just 10% in Singapore. This disparity highlights Singapore's population having better protection levels in terms of medical insurance relative to Hong Kong.
HNWIs and Future Insurance Plans
Looking ahead to 2025, 30% of individuals in Hong Kong are projected to acquire new medical insurance, with a significant 48% of HNWIs planning to purchase new policies. Conversely, only 24% of Singaporeans intend to secure additional coverage, reflecting their already extensive insurance ownership.
Motivations and Deterrents in Medical Insurance Decision-Making
In Hong Kong, motivations for purchasing new medical insurance are driven by the need to address coverage inadequacies (44%), rising medical expenses (36%), and reducing future financial risks (36%). In Singapore, the focus shifts toward mitigating financial risks (43%), exploring diverse coverage options (39%), and managing escalating medical costs (37%).
For those without insurance, high costs remain the primary deterrent, with 62% in Hong Kong and 52% in Singapore citing expense as a key barrier.
Growth Opportunities in Medical Insurance
Hong Kong presents substantial growth opportunities for insurance companies, particularly as many individuals remain uninsured. By positioning medical insurance as an affordable solution against rising medical costs, insurers can tap into this potential. Surprisingly, despite lower coverage rates, HNWIs in Hong Kong are actively considering new insurance purchases in 2025. In contrast, while the Singaporean market shows lower demand due to widespread coverage, there remains an opportunity to attract individuals by emphasizing the reduction of future financial risks and exploring low-cost solutions for those without medical insurance.
Simon Tye, CEO of MDRi, emphasizes the importance of these trends: 'Insurance firms must recognize the distinct landscapes of Hong Kong and Singapore. In Hong Kong, the opportunity lies in catering to an eager market looking for new insurance options. Meanwhile, Singapore's focus should be on providing diverse coverage solutions that effectively mitigate financial risks and address the concerns of rising medical expenses.'
Notes to editors:
The press release result is based on a survey conducted by MDRi during 31st December 2024 – 6th January 2025, measuring the sentiment and happiness level of both markets of Hong Kong and Singapore towards the year 2025, including ownership of medical insurance.
The survey engaged a total of 1,000 participants, with an equal sample size of 500 individuals from each market, to ensure a balanced representation of the demographic distribution within the respective territories.
For further information, interviews, or comments, please contact [email protected].
Hashtag: #MDRi
The issuer is solely responsible for the content of this announcement.
About The Mishcon de Reya Group
The Mishcon de Reya Group is an independent, international professional services business with law at its heart, employing over 1450 people with over 650 lawyers. It includes the law firm Mishcon de Reya LLP and a collection of leading consultancy businesses that complement the firm's legal services.
Mishcon de Reya LLP is based in London, Oxford, Cambridge, Singapore and Hong Kong (through its association with Karas So LLP). The firm services an international community of clients and provides advice in situations where the constraints of geography often do not apply. Its work is cross-border, multi-jurisdictional and complex, spanning seven core practice areas: Corporate; Dispute Resolution; Employment; Impact; Innovation; Private; and Real Estate.
The Mishcon de Reya Group includes consultancy businesses MDR Discover, MDR Mayfair (in London, Singapore and Dubai), MDR ONE, MDRi (in Hong Kong) and MDRx. The Group also includes MDR Lab, which invests in the most promising early stage legaltech companies as well as the Mishcon Academy, its in-house place of learning and platform for thought leadership.
Earlier this year, the Group announced its first strategic acquisition in the alternative legal services market, flexible legal resourcing business Flex Legal. It also acquired a majority stake in Somos, a global group actions management business.
About MDRi
Based in Hong Kong and with operations in London and Singapore, MDRi is a leading provider of business insights, empowering organizations with data-driven advice to make informed decisions and drive growth.
Through advanced analytics, industry expertise, and innovative methodologies, MDRi uncovers strategic opportunities, mitigates risks, and helps businesses stay ahead in a rapidly evolving marketplace. With a commitment to excellence and client-centricity, MDRi is revolutionizing the way organizations harness insights for success.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Global Investors Eye Bangkok's Rarest Luxury Wellness Penthouses at Award-Winning ROMM Convent
Global Investors Eye Bangkok's Rarest Luxury Wellness Penthouses at Award-Winning ROMM Convent

Associated Press

time5 days ago

  • Associated Press

Global Investors Eye Bangkok's Rarest Luxury Wellness Penthouses at Award-Winning ROMM Convent

Multi-Award Winning Development Captures International Attention with 2-Star Fitwel Certification, Asia Pacific Property Awards, and PropertyGuru Excellence Recognition BANGKOK, THAILAND - Media OutReach Newswire - 4 June 2025 - Proud Real Estate has unveiled an extraordinary investment opportunity at ROMM Convent —Bangkok's premier wellness-integrated residence in the prestigious Sathorn-Silom CBD. The only two duplex sky penthouses available, representing the pinnacle of luxury wellness living in Southeast Asia, are now available to discerning global investors. ROMM CONVENT - Duplex Sky Penthouse These architectural masterpieces have captured international attention, with ROMM Convent receiving multiple prestigious accolades including Best Condo Development and Best Architectural Design at the Asia Pacific Property Awards, Best Wellness Residences Development from PropertyGuru, and a coveted 2-Star Fitwel Built Certification—a global standard in wellness design excellence. Investors are drawn by proven returns, with rental yields of 4–5.8% per annum and capital gains averaging 3–5.4% annually. Amid a climate of accelerating international demand, ROMM Convent stands out as both a secure asset and an aspirational lifestyle investment—offering exceptional value in one of Southeast Asia's fastest-growing real estate markets. Bangkok's Luxury Market: A Magnet for Global Capital Bangkok continues to command the interest of investors worldwide, with the luxury condominium segment outpacing regional peers and anticipated to achieve sustained annual growth of 3–5% through 2027. In 2024 alone, international buyers accounted for 39% of total sales value, with large-format residences over 150 sq.m. in prime central locations witnessing robust absorption. The Silom–Sathorn district is in the midst of a transformation, with over THB 600 billion in public and private investment projected through 2035. This surge of mega-projects is redefining the urban landscape, creating new opportunities for capital appreciation and rental demand—particularly as Bangkok's tourism sector continues its strong recovery. ROMM Convent : A Sanctuary for Global Citizens Strategically positioned for expatriates, professionals, digital nomads, and retirees, ROMM Convent offers unrivaled access to both tradition and modernity. Residents enjoy proximity to Bangkok's leading international schools—including St. Andrews Sathorn, Shrewsbury International, and King's College—as well as world-class medical centers such as BNH Hospital, MedPark, and King Chulalongkorn Memorial Hospital. With average rental rates of THB 800–1,200 per sq.m. per month, the area delivers healthy yields of 4–5.8% per year and robust capital gains of approximately 3–5.4% annually, underpinned by consistently high tenant demand. The Pinnacle of Wellness-Integrated Living The Duplex Sky Penthouses at ROMM Convent are a masterclass in architectural innovation and holistic well-being. Each residence spans 418.61–467.86 sq.m., offering house-like layouts with soaring 6.45-meter ceilings and panoramic skyline views, including Bangkok's most iconic landmarks. Private rooftop gardens create a tranquil green haven, seamlessly visible from both living and bedroom spaces. Exceptional Features Include: • Ultra-Exclusive Ownership: Only two duplex penthouses available. • House-Like Living: Two-story layout located in the heart of Bangkok's CBD • Skyline Views: Panoramic vistas in three directions, including iconic landmarks like MahaNakhon and One Bangkok • Private Rooftop Garden: A serene green escape visible from the main living and bedrooms • Signature Design Elements: Full-height glass, custom wellness detailing, and a serene rooftop retreat. • Gourmet Entertaining: Ice Jade kitchen island, Gorenje ORA ITO appliances, and a 46-bottle wine cellar. • Sophisticated Finishes: Engineered walnut floors, stone-clad kitchens, premium fixtures, and bespoke cabinetry. • Grand Proportions: Four bedrooms, five bathrooms, powder room, and a flexible multi-purpose space. Wellness Technology & Privileged Services: • 2-Star Fitwel Certified Wellness: Recognized global standards in health-optimized living. • 24/7 Health Butler Concierge: Personalized healthcare coordination and support. • Six Levels of Wellness Amenities: Thoughtfully curated for holistic mind-body well-being. • Smart Home Ecosystem: Advanced technology for air quality, energy efficiency, and comfort. • Exclusive Healthcare Partnerships: VVIP privileges with BNH Hospital and BeDee by BDMS. Unmatched Value in Bangkok's Central Business District Starting at just THB 290,000 per sq.m., ROMM Convent's Duplex Sky Penthouses represent one of the most compelling luxury investments in the Sathorn district—delivering exceptional value compared to global property capitals. Ownership is further enhanced by immediate access to VVIP medical privileges at BNH Hospital including special discounts and personalized care from Thailand's top-tier medical professionals—, ensuring both peace of mind and premier healthcare for residents and their families. Limited International Allocation: Secure Your Early Investor Advantage As foreign ownership quotas rapidly reach capacity, Proud Real Estate is pleased to offer the exclusive Early Investor Package (available until June 30, 2025). This limited-time opportunity includes bespoke layout customization and privileged access to tailored services—making now the optimal moment for international investors to secure their stake in one of Bangkok's most rarefied addresses. Invest in an Iconic Lifestyle at ROMM Convent – Where Wellness Meets Luxury Seize the opportunity to own one of the last two Duplex Sky Penthouses at ROMM Convent, where visionary design, holistic wellness, and world-class investment potential converge. Availability is strictly limited—act now to elevate your lifestyle and portfolio with Bangkok's most coveted luxury residence. For more information and personalized assistance, please visit Proud Real Estate or call +662-026-8999. Note: This press release contains forward-looking statements about market performance and investment returns. Actual results may vary. Investors should conduct their own due diligence before making investment decisions. Hashtag: #ProudRealestate #AllisWell #RommConvent #LuxuryWellnessResidences #CondoSathorn #CondoHighRise #Condo #Bangkok #CBD The issuer is solely responsible for the content of this announcement. PROUD REAL ESTATE PUBLIC COMPANY LIMITED Proud Real Estate is Thailand's leading luxury wellness-focused property developer, renowned for creating holistic living environments that seamlessly integrate health optimization, sustainability, and timeless design. With a portfolio of internationally awarded projects, Proud Real Estate consistently delivers above-market investment returns while setting new benchmarks in luxury and resident well-being. The company gained global recognition for the development of InterContinental Residences Hua Hin, one of only eight world-class branded residences under the InterContinental name—further solidifying Proud's reputation for excellence in luxury real estate.

Life expectancy of Singapore's population rises in 2024, marking improvement over Covid-19 years
Life expectancy of Singapore's population rises in 2024, marking improvement over Covid-19 years

Yahoo

time27-05-2025

  • Yahoo

Life expectancy of Singapore's population rises in 2024, marking improvement over Covid-19 years

SINGAPORE – The life expectancy at birth for the Singapore population in 2024 improved from both 2023 and over the past decade, said the Department of Statistics on May 27. Life expectancy of Singapore residents rose by 0.9 years in the past decade from 82.6 years in 2014 to 83.5 years in 2024. The latest figure is also slightly higher than 83.2 years in 2023. This follows a dip in life expectancy between 2020 and 2023, which was attributed to the impact of the Covid-19 pandemic. Life expectancy refers to the average number of years a person may expect to live, if the mortality rates apply throughout their lives. The information is contained in the Report On The Complete Life Tables For Singapore Resident Population 2023-2024 released by the Department of Statistics. Singapore residents refer to Singaporeans and permanent residents. While both genders enjoyed a longer life expectancy in the past decade, women have a longer life span compared with men. The life expectancy at birth for women was 85.6 years in 2024, compared with 81.2 years for men. Over the last decade, life expectancy for men improved by 0.9 years from 80.3 years in 2014, while the female life expectancy improved by 0.8 years from 84.8 years in 2014. The report released on May 27 said that life expectancies for 2020 to 2023 were affected by the higher mortality rates arising from the Covid-19 pandemic. In 2021, The Straits Times reported that Singapore residents' life expectancy fell for the first time in history since such data became available more than 60 years ago, and this was due to higher mortality rates arising from the Covid-19 pandemic. The life expectancy at birth fell by about 10 weeks from 83.7 years in pre-pandemic 2019 to 83.5 years in 2021. Source: The Straits Times © SPH Media Limited. Permission required for reproduction Discover how to enjoy other premium articles here

Intermittent Hypoxia-Hyperoxia Therapy (IHHT) Launched: Breakthrough Breathing Therapy for Heart, Brain, and Healthy Aging
Intermittent Hypoxia-Hyperoxia Therapy (IHHT) Launched: Breakthrough Breathing Therapy for Heart, Brain, and Healthy Aging

Associated Press

time14-05-2025

  • Associated Press

Intermittent Hypoxia-Hyperoxia Therapy (IHHT) Launched: Breakthrough Breathing Therapy for Heart, Brain, and Healthy Aging

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 14 May 2025 - Ai Mediq SA today officially launched Intermittent Hypoxia-Hyperoxia Therapy (IHHT), a science-backed, non-invasive breathing therapy that strengthens the cardiovascular system at its cellular core. By training the body to adapt to fluctuating oxygen levels, IHHT enhances heart function, improves metabolic efficiency, supports cognitive health, and reduces inflammation. IHHT cycles between low-oxygen (hypoxia) and high-oxygen (hyperoxia) breathing intervals, acting like 'interval training for your cells.' It optimizes oxygen use, lowers inflammation, and boosts resilience without the risks associated with continuous hypoxia. Rooted in oxygen-sensing molecular mechanisms, a Nobel Prize-winning discovery, IHHT triggers regenerative cellular processes. Devices like ReOxy® and HIBERG® use Self-Regulated Treatment (SRT) technology to personalize sessions based on real-time data such as heart rate and oxygen saturation, ensuring optimal and safe results. Clinical Evidence A 2023 review published in Metabolites analyzed 16 clinical studies ( ), confirming IHHT's benefits across cardiovascular, cognitive, and metabolic health: Ripple Effects of IHHT Beyond the proven benefits, IHHT enhances cognitive function, supports metabolism and longevity, improves athletic recovery, and reduces systemic inflammation. From Clinical Evidence to Real-World Application: ReOxy® and HIBERG® Once reserved for elite athletes and clinical trials, IHHT is now accessible to both medical professionals and health-conscious individuals: ReOxy® is a CE-certified medical device designed for clinical settings. It delivers fully automated IHHT protocols tailored to individual patients, making it ideal for cardiology, rehabilitation, and integrative medicine practices. HIBERG® adapts the same core technology for personal use, offering guided breathing sessions to support recovery, stress relief, sleep, and energy balance. It's a powerful wellness solution for anyone seeking performance and longevity. Both devices are powered by SRT-Technology, ensuring personalised, safe, and effective treatment every session. Hashtag: #AiMediqSA #IHHT The issuer is solely responsible for the content of this announcement. About Ai Mediq SA Headquartered in Luxembourg, Ai Mediq SA develops advanced breathing therapies backed by clinical research. Its flagship innovations, ReOxy® and HIBERG®, bring cutting-edge, non-invasive solutions into everyday health practices.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store